|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.03 USD | -2.80% |
|
-7.16% | +74.54% |
| 07-27 | B. Riley Raises Price Target on TG Therapeutics to $86 From $55, Keeps Buy Rating | MT |
| 07-07 | Moderna, TG Therapeutics, Agios Pharmaceuticals Q2 Results May Face Increased Scrutiny, BofA Says | MT |
| Market Cap | 7.37B 6.41B 5.97B 5.48B 10.34B 704B 10.5B 70.33B 27.6B 350B 27.69B 27.08B 1,175B | P/E 2026 * |
40.4x | P/E 2027 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 7.37B 6.41B 5.96B 5.47B 10.34B 703B 10.5B 70.28B 27.58B 350B 27.68B 27.07B 1,174B | EV / Sales 2026 * |
7.82x | EV / Sales 2027 * | 5.24x |
| Free-Float |
88.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: TG Therapeutics, Inc.
| 1 day | -2.80% | ||
| 1 week | -7.16% | ||
| 1 month | -5.30% | ||
| 3 months | +54.03% | ||
| 6 months | +76.79% | ||
| Current year | +74.54% |
| 1 week | 51.55 |  | 57.58 |
| 1 month | 51.15 | | 59.3 |
| Current year | 26.76 | | 59.3 |
| 1 year | 25.28 | | 59.3 |
| 3 years | 6.46 | | 59.3 |
| 5 years | 3.48 | | 59.3 |
| 10 years | 3.32 | | 59.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Weiss
CEO | Chief Executive Officer | 60 | 28/12/2011 |
Sean Power
DFI | Director of Finance/CFO | 44 | 28/12/2011 |
Jenna A. Bosco
IRC | Investor Relations Contact | - | 30/11/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Weiss
CHM | Chairman | 60 | 28/12/2011 |
Laurence Charney
BRD | Director/Board Member | 79 | 29/02/2012 |
Yann Echelard
BRD | Director/Board Member | 62 | 08/11/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/01/26 | Don | Director | 43,197 | 0.0272% | ||
| 08/01/26 | Free | Chief Executive Officer | 622,000 | 0.3918% | ||
| 08/01/26 | Free | Chief Financial Officer | 90,000 | 0.0567% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.80% | -7.16% | +46.56% | +151.47% | 7.37B | |
| -0.53% | -3.95% | +55.23% | +152.74% | 1,024B | |
| +0.21% | -2.68% | +55.61% | +53.02% | 618B | |
| -2.51% | -3.25% | +32.76% | +67.76% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.14% | -0.24% | +34.41% | +39.01% | 297B | |
| -0.69% | -0.30% | +11.55% | +12.93% | 264B | |
| -7.37% | -4.40% | -2.54% | -43.87% | 209B | |
| -0.64% | +2.43% | +30.52% | +64.49% | 208B | |
| -0.82% | +0.70% | +15.96% | +71.01% | 162B | |
| Average | -1.52% | -1.79% | +31.76% | +59.92% | 358.11B | |
| Weighted average by Cap. | -0.99% | -1.94% | +39.25% | +73.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 943M 819M 763M 700M 1.32B 89.97B 1.34B 8.99B 3.53B 44.79B 3.54B 3.46B 150B | 1.29B 1.12B 1.05B 960M 1.81B 123B 1.84B 12.33B 4.84B 61.42B 4.85B 4.75B 206B |
| Net income | 200M 174M 162M 149M 281M 19.14B 286M 1.91B 750M 9.53B 753M 736M 31.95B | 483M 420M 391M 359M 677M 46.08B 688M 4.6B 1.81B 22.94B 1.81B 1.77B 76.92B |
| Net Debt | -4.69M -4.08M -3.8M -3.48M -6.58M -448M -6.68M -44.74M -17.56M -223M -17.62M -17.23M -748M | -601M -523M -486M -447M -843M -57.39B -857M -5.73B -2.25B -28.57B -2.26B -2.21B -95.81B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | US$52.03 | -2.80% | 2,489,895 |
| 30/07/26 | US$53.53 | +0.09% | 2,851,516 |
| 29/07/26 | US$53.48 | -2.53% | 2,916,396 |
| 28/07/26 | US$54.87 | -1.58% | 2,326,484 |
| 27/07/26 | US$55.75 | -0.52% | 1,680,373 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TGTX Stock
Select your edition
All financial news and data tailored to specific country editions
